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ABSTRACT

Multiple Reaction Monitoring (MRM) is a powerful tandem mass spectrometry
(MS/MS) tool frequently implemented in proteomic studies to provide targeted analysis
of proteins and peptides. The selectivity that MRM delivers is so strong that it provides
the quadrupole mass spectrometers (QQQ), on which it is commonly employed, with
pertinence to proteomic studies that they would otherwise lack for their relatively low
resolution. Additionally, this increased level of selectivity is sufficient to supplant
complicated fractionation techniques, additional dimensions of chromatography, and 24
hour long MS/MS experiments in simplistic biological samples. But there is a deficiency
of evidence to determine the applicability of MRM to complex samples such as those
containing the entire proteome of single cellular organisms. These samples are often
employed to profile entire metabolic pathways at a cellular level using the complete set
of proteins involved in the pathway’s characteristic enzyme driven reactions. This
sweeping view of gene expression is vital to understand cellular response, and profiling
these expressions would benefit greatly from the introduction of MRM as a viable
approach for characterizing metabolic networks. This thesis takes two significant steps
towards this viability by first demonstrating MRM reproducibility in complex samples,
and characterizing degrees to which certain design related factors influence the quality
of these MRM. The next step applies knowledge gained by the first to exhibit the MRM
profiling of a vital metabolic pathway from a complex sample. This step also
demonstrates the self-sufficient utility an ab initio method, based on proteins and
peptides predicted from the genome sequence, for designing MRM. Combining the ab
initio design approach with the MRM of complex samples represents substantially
shorter experimental preparations for profiling metabolic networks, and renders the
characterization of gene expression on a cellular level as a more widely accessible
study within proteomics.
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Chapter 1: Introduction to Targeted Proteome Characterizations

1.1 Advent of Systems Biology
As a relatively new and emerging paradigm in bioscience, Systems Biology is a
remarkably large and interdisciplinary field that combines computational modeling, highthroughput analytical methods, and state of the art data analysis in the holistic study of
cellular metabolic pathways [1-4]. Rather than concentrating on isolated components,
this integrated approach studies concerted biological activities as a unified network,
which provides context for their interwoven causal nexus, and characterization of their
mechanisms and purposes at the cellular level [5]. This new characterization insight
provides a better understanding of cellular responses to environment, disease, and
intercellular communications by offering a more direct connection between gene
expressions within a cell and the stimuli that provoked them [3].
Molecular biology defines these gene expressions by the molecules and reactions
they comprise. A cell’s genes are contained in strands of deoxyribonucleic acid (DNA),
and a gene expression begins when a cell transcribes a portion of its DNA to ribonucleic
acid (RNA). Then genetic information is translated from RNA into functional
macromolecules known as proteins. Some of these proteins are enzymatic which
means that they catalyze reactions in life-sustaining metabolic pathways, such as
glucose digestion and DNA synthesis[5, 6]; the latter example typifies the reticulate
causal nexus mentioned earlier. Each protein catalyzes a specific reaction, each viable
combination of reactions maps out a specific pathway, and each pathway is activated by
expressing the genes for the proteins that drive its reactions. Due to their central role in
this process, proteins provide a link between pathways and genes, and consequently
they are a medium for monitoring gene expression[5]. This means that proteins can
reveal detailed information about a cell’s structure and metabolic activity; which for
bacteria, a single-cell life form, this means they also provide a comprehensive molecular
profile of the entire organism.
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1.2 Proteomics
One component of the systems biology approach to molecular biology is proteomics,
which is defined as profiling and characterizing entire metabolic pathways by identifying
complete sets of proteins. Such large scale profiling requires using a protein’s intrinsic
properties to not only uniquely identify and accurately quantify it, but also to separate it
from other proteins to assist these measurements. Applying this practice to multiple
proteins with multiple properties, while providing meaningful qualitative and quantitative
data in one experiment, requires high throughput analytical techniques and instruments
possessing both a wide dynamic range and an elevated level of identification.
A staple analytical technique in proteomics is mass spectrometry (MS), which
encompasses a multitude of strategies applied across a variety of instrumental
configurations. Like high performance liquid chromatography (HPLC) and twodimensional polyacrylamide gel electrophoresis (2D-PAGE), MS is a high throughput
technique that can analyze thousands of proteins in one experiment; however, it
provides significant increase in identity specificity over HPLC and 2D-PAGE. Rather
than using a protein’s affinity to stationary phase (an external interaction), MS identifies
proteins by their mass to charge ratio (m/z, an intrinsic chemical property). As an
additional performance capability, HPLC can be coupled indirectly or directly to MS
(offline or online LC-MS) to enhance both separation and subsequent MS identification,
and can be augmented by adding a second chromatographic dimension before MS that
operates on a different intrinsic property (2D-LC).
Further specificity in LC-MS identity is achieved through a very common strategy
known as bottom-up proteomics. This strategy begins by digesting the proteins into
peptides for MS analysis, then adding a second MS step that fragments (MS/MS). The
fragments identify the peptides and the peptides identify the protein, which minimizes
ambiguity at the protein and peptide level. Fragment based identifications are facilitated
by a systematic nomenclature that identifies their portion of the peptide sequence.
Each peptide has an amino-terminus and a carboxyl-terminus (N- and C- terminus
respectively), and when a peptide ion breaks, the charge remains on either the N- or Cterminus leading to the detection of attached fragment. N-terminus ions are labeled a-,
2

b-, or c- type ions, while C-terminus are labeled x-, y-, and z- type ions, as seen in
Figure 1.1. The three possible labels arise from three possible peptide bonds that could
break to form a fragment, and ions of one terminus are complementary to ions of the
other. Specifically, a- and x- type ions are complementary and originate from breaking
the alpha carbon to carbonyl carbon bond, b- and y- ions are complementary and
originate from breaking the carbonyl carbon to amide nitrogen bond, and c- and z- type
ions are complementary and originate from breaking the alpha carbon to amide
nitrogen. Since these bonds can occur multiple times in a peptide, with multiple
possibilities of each ion type, the bonds are numbered in sequence from both termini,
with each ion type numbered in turn. For example a peptide with three carbonyl-amide
bonds, such as the one in Figure 1.1, will have three b-type and three y-type ions as
seen in Figure 1.2, with the complementary ions being b-1 and y-3, b-2 and y-2, and b-3
and y-1.
As one of the preferred analytical methods in proteomics, bottom-up 2D-LC-MS/MS
offers a very high level of specificity, yet such experiments can still run as long as 24
hours to accommodate the complexity of proteomic samples. Although individual run
times can be shortened by performing the first LC separation offline (fractionation), this
strategy requires multiple runs and time consuming sample preparation.
The various methods of proteomic MS can be divided into two categories: global and
targeted, and each one presents advantages and challenges. The global approach is
and enables the single experiment profiling of multiple metabolic pathways under that
sample’s conditions; this can also retroactively apply to proteins and pathways not yet
linked. However, with so many peptides and fragments to separate and scan from a
continuous flow, some less abundant proteins will not be identified, which in turn means
that some metabolic pathways may be expressed but lack enough data for a profile.
The targeted approach looks for specific proteins in order to profile select metabolic
pathways. Targeted experiments require prior knowledge of protein-pathway links, and
they ignore a large majority of proteins, hence the data from these experiments will not
be applicable outside of the chosen pathways. However, this focused scanning allows
targeted experiments to measure proteins that would otherwise go undetected, and to
3

Figure 1.1 Diagram of peptide fragment labeling, courtesy of Matrix Science [7]

Figure 1.2 B- and y-type ions to show charge placement, courtesy of Matrix
Science [7]
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profile pathways of interest that would otherwise lack sufficient data. Additionally, this
narrow view can facilitate the measurement of absolute protein concentrations, and thus
better measure the scope of a gene’s expression.

1.3 Targeted Proteomics
Although targeted detection of proteins and targeted MS have both existed for
several decades, targeted MS is a relatively new addition in proteomics. Older targeted
techniques, such as affinity chromatography and western blotting, exploit the selective
binding between enzymes and substrates, or antigens and antibodies to achieve highly
specific protein isolation and detection[8]. However, these techniques rely on the
careful execution of complex and time consuming sample preparations and processes.
Targeted MS analysis is based on an MS/MS technique known as selected reaction
monitoring (SRM), and similar to a previously discussed concept, it utilizes mass
instead of interaction to achieve specific isolation and detection. Within MS/MS the
select profiling of SRM differentiates it from global MS/MS which is designed to identify
thousands of proteins and peptides in one experiment. Global analysis scans all
peptide charge-state (precursor) m/zs and all fragment m/zs, while SRM scans for one
specific precursor m/z, with one specific fragment m/z. Each pairing of specific m/zs,
one precursor with one fragment, is called a transition, and when multiple transitions are
targeted, the experiment is called a multiple reaction monitoring (MRM). Each protein
contains a number of unique amino acid sequences found among some of the peptides
it comprises, and MRM can identify such a peptide by detecting its unique transitions.
These unique peptide identities provide protein identities as specific as those obtained
by traditional targeted techniques.
Being both a targeted approach and an MS method, MRM offers a few unique
advantages. First, compared to other MS approaches, it requires less scans per
experiment, which affords it more time per scan while reducing overall time for the
experiment. Next, MRM’s selective detection allows it to identify low abundance proteins
with less fractionation than global MS, and MRM can even be performed with only one
dimension of chromatography (1D-LC). Also, because isolation and detection take
5

place inside the instrument, MRM requires far less sample preparation than other nonMS targeted approaches. Finally, MRM can be performed on relatively low cost, and
readily available, instruments without requiring expensive antigen tags, making it one of
the least expensive options of both targeted and MS methods.
Despite its youth, MRM is a widely accepted method, and as it is backed by
substantial precedent, MRM related research continues to grow for both proteomics in
general, as well as for its own development [9]. The instrumental backbone for MRM
research and application has historically been the triple quadrupole mass analyzer
(QQQ), but utilization of the recently developed quadrupole-Orbitrap (Q-Exactive) is
steadily increasing as this instrument offers advanced resolution [10, 11]. Other
recently proposed advancements include methods for single-transition-based MRM
identities and standard protocols to evaluate MRM system performance [11, 12].
Currently, employment of MRM includes profiling protein networks, quantifying posttranslational modifications, and disease biomarker verification[9]. Recent specific
examples of MRM applications include research by Gall et al[6] in developing a sub-5minute method for measuring blood plasma concentrations of rufinamide in low volume
samples, and another study by Li et al [13] developed a method for quantitative
measurement of arenobufagin in rat plasma, which was also a 5 min method.
Representing samples outside of plasma, Vierikova et al [14] developed an MRM
method for determining the natamycin content of cheese in a 14 min measurement.
The success of proteomic MRM is due in large part to advanced bioinformatics tools,
such as the popular software application Skyline [15]. The applicability of this software
is evident throughout every step of MRM development; specifically, it can be used to
design, evaluate, and modify a method, as well analyze final MRM data. Skyline’s
versatility will be discussed further in chapter two.

1.4 Thesis Objectives
Thus far, MRM has been applied to relatively simplistic sample sets, such as blood,
serum, urine, or even cheese. Yet it poses the potential to interrogate large
unfractionated samples containing whole proteomes of multiple organisms. Placing
6

greater emphasis on tuning the MRM methods and instruments allows the sample to
remain complex; this reduces the time, money, and mistakes risked in both planning
and executing individual sample preparations for each study.
However, designing and tuning a specialized MRM for each study is a daunting task
that presents its own potential errors and fruitless endeavors. Meaningful experimental
design requires guidelines that point out subtle yet fatal flaws, and help maintain a focus
on pertinent issues. The work presented in this thesis was devised to offer such
guidance by first identifying factors that have a potentially significant impact on MRM
design, then conducting comparative MRM’s that focus on those factors, and finally
evaluating both the quality of the resulting MRM data and the effects of each factor on
that quality.
The research conducted in pursuit of this goal was split into two projects, with two of
the following chapters of this thesis dedicated to discussing how each was designed,
executed, and evaluated. The first project, as presented in chapter three, fields the
fundamental question: “Can MRM of peptides in an unfractionated sample, containing
whole proteomes of multiple organisms, be reproducibly accomplished?” Additionally,
this project identifies and investigates chromatographic congestion and peptide
abundance for their potential influence on MRM quality. Chapter four encompasses the
expansion project, which responds to the challenge: “Can such an ambitious MRM be
employed to profile an entire metabolic pathway?” In the course of facing this gauntlet,
this project also provides a comparison of two competing methods for MRM design,
empirical and ab initio. Each of these projects are complimentary to the other; the first
is a proof of concept study that provides the basis for the second, which itself is an
applicable demonstration that brings relevance to the first. Together, these symbiotic
projects present a defendable method for designing an MRM to profile metabolic
pathways in a complex sample of complete proteomes.
With the success of these projects in meeting both their individual goals and the
overarching objective, this thesis will deliver three contributions to the advancement of
proteomic MRM within systems biology. First, it will demonstrate that MRM’s strength in
eliminating a significant amount of sample preparation can be further applied to samples
7

of complete proteomes. Second, this thesis will explore the limits of how complex an
MRM sample can be while still returning meaningful data. Finally, the work presented in
this study will demonstrate the ability of MRM to characterize a specific metabolic
pathway in a complex sample, containing the complete proteomes of several
organisms, without fractionation, in 60 min.

8

Chapter 2: Experimental Approach for Targeted Proteomics

2.1 Overall Experimental Design
Fulfilling the goals of this thesis relied on carefully designing the experiments for
each project, based on a significant understanding of biological samples, established
methods, and instrumental mechanics. This chapter will outline and define these
concepts through a detailed discussion of the experimental designs. First, the contents
of the selected sample will be described to define its merit in testing MRM designs. This
will be followed by a discussion on relevant sample preparation, sample loading, and LC
methods. Next, a brief explanation of the ion source will connect LC to MS/MS, and
explain the origin of multiple peptide precursors. The two sections that follow will cover
the two types of mass analyzers employed by this thesis, and will describe how both
instruments play a role in each project. These sections will also serve as a comparison
for how each mass analyzer achieves MS/MS. Finally, this chapter will focus on the
software employed in collecting, calculating, and evaluating data. This portion will also
look closer at the specific contribution provided by Skyline.

2.2 Microbial Sample Selection
A model synthetic microbial consortium consisting of the microbes Escherichia coli,
Rhodopseudomonas palustris, Ignicoccus hospitalis, and Nanoarchaeum equitans (E.
coli, R. pal, I. hos, N. equi) was prepared to evaluate the design and execution of each
MRM in a moderately complex but highly controlled biological system. For this four
isolate system (4-iso) there are approximately 11,000 possible proteins, based on
genome evaluations. Assuming that each microbe could express about one-half of its
genome products under one growth condition would suggest a possible pool of about
5,500 protein products. This would yield over 80,000 possible tryptic peptides in the
sample.

9

2.3 Sample Preparation and Separations
The samples were prepared and loaded according to in-house techniques and then
separated by an in-house LC method that was modified for a 60 min 1D-LC run; the
polar and nonpolar solvents used therein were also prepared in house[16]. The polar
solvent (solvent A) is 5% acetonitrile (ACN), 95% HPLC-grade water, and 0.1% formic
acid; the nonpolar solvent (solvent B) is 70% ACN, 30% HPLC-grade water, and 0.1%
formic acid.
The microbial samples were pulse-sonicated for 2 min and boiled for 5 min in a
sodium dodecyl sulfate (SDS) solution, resulting in cell lysis, and yielding proteins which
were immediately precipitated with trichloroacetic acid (TCA). After being washed and
re-solubilized, the proteins were then digested with sequencing-grade trypsin for
approximately 12 hours, which cleaved the proteins into their constituent peptides at
lysine and arginine residues. For each MS/MS run, 5 to 10 μg of peptides were bombloaded onto a fused silica back column packed to approximately 5 cm with Kinetix C18
reverse-phase (RP) resin, and washed offline with solvent A. Next, the back column
was placed in line behind a nanospray emitter that was approximately 10 cm long and
packed full length with C18 RP resin. The peptides were then separated by 1D-LC with
a 60 min gradient from 2% solvent B to 90% solvent B, at a flow rate of 300 nl per
minute.

2.4 Electrospray Ionization/Nano-Electrospray
Nano-flow electrospray ionization (Nanospray) was employed for interfacing the LC to
the MS/MS. Figure 2.1 shows this atmospheric pressure interface, and Figure 2.2
illustrates the basic operation of nanospray in which the peptide laden solvent is passed
through a charged needle to form charged droplets. These charged droplets accelerate
through a potential gradient to the inlet port of the spectrometer; meanwhile the solvent
evaporates until the droplets break into charged peptide ions. Solvents A and B both
contain ACN, which is a volatile organic that aids in solvent evaporation; they also both
contain formic acid to increase droplet conductivity. By utilizing nanoliter flow rates,
nanospray decreases solvent volume and increases ion formation. For both projects,
10

Figure 2.1 Nanospray Interface for LC-MS/MS. The pulled nanospray tip of the
fused silica tubing is shown on the right; this connects the flow from the LC
column to the ESI source of the MS and is open to atmosphere. This nanospray
tip is localized a few mm. away from the heated metal capillary (shown on the left)
of the ESI source of the MS.
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Figure 2.2 Basic illustration of nano-flow electrospray ionization, courtesy of
Dionex[17]
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nanospray flowed at 300 nL per minute, as set by the LC pump. A voltage between
2300 and 2700 volts was used to establish the electrospray ionization conditions.
The amount of charge a peptide ion receives can vary, which gives rise to multiple
precursors ions for one peptide. Although they have a minimal difference in mass,
these precursors will differ greatly in m/z according to their charge. Typically,
nanospray ions range in charge from +1 to +4, but +2 ions are the most commonly
detected by MS/MS. This is because +1 ions often lack enough charge repulsion to
fragment, while the +3 ions and up have too much charge repulsion to be easily
formed[18].

2.5 Global Proteome Characterization using 1D-LC-MS/MS
After peptide elution from 1D-LC and ionization by nanospray, the ions enter the MS
and are targeted for tandem mass spectrometry (MS/MS). Within the confines of this
study, all MS/MS analysis, both global and targeted, was solely performed in the cells of
quadrupole mass analyzers. A quadrupole cell is a square array of four hyperbolic
metal rods to which voltages are applied for the manipulation of ion trajectories. Any
two rods that are opposite each other in the array are connected electrically, and as this
occurs twice in a quadrupole, it is better to view the array as being two pairs of rods
rather than four individual rods.
All global 1D-LC-MS/MS measurements were made using a Thermo-Fisher LTQ-Velos
Pro linear trap quadrupole mass spectrometer (LTQ). An LTQ is one continuous cell,
split into three array sections, designed to trap ions inside and then analyze them. A
diagram of an LTQ is shown in Figure 2.3. An ac voltage at a constant radio frequency,
known henceforth as RF, is applied to the rods to guide ions along the axis of the cell.
Meanwhile three separate dc voltages are applied to the three sections to create
potential wells that confine axial ion movement to be within the cell, and effectively trap
the ions. Before each analysis, the trap opens for a discrete duration to accumulate
ions, and a helium damping gas in the cell helps slow incoming ions to facilitate trapping
by the voltages. During and after analysis, ions are ejected through slots in the center
section, for which it is termed the exit rods.
13

Figure 2.3 Basic diagram of linear ion trap quadrupole rod assembly, courtesy of
Thermo Fisher Scientific[19]
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To perform MS/MS, the LTQ accumulates ions and then conducts MS1 isolation,
precursor fragmentation, and MS2 scan out. This MS/MS is termed tandem in time, as
the three steps occur sequentially and in the same cell. The latter quality is enabled by
applying, to the exit rods, an additional ac voltage that can vary in frequency or even
comprise several at once. All ions in the trap oscillate at discrete frequencies as
determined by both their m/zs and the RF amplitude; and when the ac’s frequency
matches an ion’s, they resonate, and impart the ion with enough kinetic energy to cause
its ejection from the trap or its collisions within.
During MS1, the ac is multi-frequency and can resonate with ions of a handful of
m/zs at once. A ramp in the RF, from low to high amplitude, excites one handful after
another into resonance to cause their ejection into waste. But a discrete gap in the acRF combination matches one specific m/z, which results in these precursor ions being
isolated in the cell. The ac frequency then changes to resonate with the precursors, but
without an RF ramp, so they stay in the cell and collide with the helium damping gas.
The collisions convert the ions kinetic energy into internal energy, causing them to
dissociate into fragments in a process known as collision induced dissociation (CID); the
resulting fragments have different m/zs and thus different frequencies. Finally, MS2
scan out occurs by setting the ac to one frequency, and ramping the RF to move
fragment ions into resonance, one at a time, according to their m/z. This results in the
sequential ejection of fragment ions, but this time into the detector. It is important to
specify at this point that CID predominantly produces b- and y-type ions [7, 20], and for
the remainder of this thesis, all fragments can be assumed to be one of only these two
types.
If just an MS1 scan is desired, as to detect any precursors present at a given time,
the LTQ does not isolate or fragment, but only scans ions out as described above. This
is important, as the LTQ can use MS1’s to guide itself through global MS/MS, and
consequently boost the efficiency therein. Specifically, the LTQ runs an MS1 scan and
picks the most intense precursors detected, then it runs consecutive MS2 scans on
each pick, starting with the most intense; user input predetermines the number of picks
per MS1 scan, and number of MS2 scans per pick. This process is known as a data15

dependent scan, and it is repeated over the entire duration of a global MS/MS
experiment. As the LTQ is picking the most intense precursors from an MS1, it
temporarily ignores any precursors picked from prior MS1 scans, and this duration is
also set by user input. This process is termed dynamic exclusion, and its purpose is to
provide MS2 scans on precursors that may be less intense, but are no less important.
Global MS/MS experiments in this study were run with one MS1 scan followed by
twenty MS2 scans, one each for twenty precursors, and a dynamic exclusion time of 1
minute. The resolution of a scan is determined by the mass of a detected ion, divided
by the difference in mass between two adjacent distinct ions. In the case of peptides,
with masses from 400 to 1700 Daltons, being able to separate a 0.5 Dalton difference
requires a resolution of 800 to 3400. Both MS1 and MS2 have a resolution of 1000,
which can separate peptides with an approximately 0.5 to 1.5 Dalton difference in mass,
depending on the mass of the peptides being separated.

2.6 Operational Principles of the QQQ-MS System
A Thermo TSQ Quantum triple quadrupole mass spectrometer (QQQ) was used for
all the targeted 1D-LC-MS/MS measurements in this study. A QQQ is three singlearray cells that are isolated and arranged in sequence, as seen in Figure 2.4. There is
no axial trapping, but rather a continuous ion stream travels from source to detector,
through each cell along its axis. Ion oscillation stability is controlled through variable RF
and dc voltages, where RF are applied to all three cells, but dc are applied only to the
first and third. Again it is best to view the rods of each cell as two pairs, and the
voltages applied to one pair of rods are of equal amplitude but opposite sign as those
applied to the other pair, as seen in Figure 2.5. An additional dc voltage is used as an
offset and will be referenced only as “offset” to prevent confusion. The offset is applied
to all three cells, and with equal amplitude and sign for their two rod pairs. It controls
ion acceleration, and thus controls ion translational kinetic energy (TKE).
MS/MS on a QQQ is termed tandem in space, because it is done by distributing the
three steps, in sequence, among the QQQ’s three cells. The first cell, designated Q1,
operates as the MS1 mass analyzer and isolates precursor ions, according to their
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Figure 2.4 Basic diagram of a triple quadrupole mass analyzer, courtesy of
Thermo Fisher Scientific[21]
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Figure 2.5 Diagram of electrical connection for the quadrupole rod assembly of
the QQQ, courtesy of Thermo Fisher Scientific[21]
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m/zs, by applying varying ratios of RF to dc. A given ratio of voltages will cause
precursor ions of a specific m/z to have controlled oscillations and travel through Q1 to
the next cell. Ions of any other m/z will oscillate out of control and either crash into the
rods or be ejected from Q1. As the RF and dc are varied, their ratio is changed, and
ions of a new m/z are brought into stable oscillation, while ions of the previous m/z join
the others in instability.
Precursor ions, isolated in Q1, then enter the second cell, termed Q2, which
functions as the collision cell. There is no dc applied to Q2, but there is a variable RF
that provides stable oscillations to ions over a wide m/z range. Also, Q2 contains argon
gas for the precursors to collide with and subsequently undergo CID; the energy for
which is provided by an ion’s TKE as determined by the offset. The ions follow a path,
set by the voltages, through a curve in Q2 (Figure 2.4), while neutral molecules miss the
turn and are ejected from the cell, thus this simple curve dramatically reduces noise in
the spectrum. The fragment ions generated in Q2 then pass into the third cell, Q3,
which is the MS2 mass analyzer. Q3 operates by the same mechanism as Q1, and
isolates fragment ions one after another for passage to the detector.
There are a couple of important differences between MS/ MS on a QQQ and that on
an LTQ. By using argon instead of helium as a collision gas, QQQ fragmentation is
more extensive, and requires less kinetic energy, than that of LTQ. Because argon is
bigger and heavier than helium, a collision with argon converts more of the ion’s kinetic
energy into internal energy than for a collision with helium. The other difference is
MS/MS scans are faster on the QQQ than on the LTQ. Since the QQQ is tandem in
space, there is no waiting for ions to accumulate before isolation begins, or waiting for
one step to finish before starting the next. Precursor isolation, CID, and fragment
isolation are simultaneously performed in their respective cells. However, the ion
stream experiences them sequentially, and on the fly, as it passes from one cell to the
next; and MS/MS takes only as long as ions going from source to detector. That is to
say, tandem in space scans occur in real time in as little as 0.001s; this renders the
QQQ ideal for targeted MS/MS, which in turn affirms its value to proteomics despite
have unit resolution.
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2.7 Targeted Proteomics with Multiple Reaction Monitoring (MRM)
The construction of a proteomic MRM method involves selecting several of a
protein’s unique peptides, then selecting several unique transitions for each peptide.
This collection is called a transition list, and is used by the QQQ’s operating software to
guide the targeted detection of transitions. The resulting spectra can then be used for
the selective identification and measurement of peptides. Naturally, as more transitions
are detected with strong signals, confidence in the identity of the target peptide
increases, and the possibility of an interference peptide being identified decreases. An
interference peptide is a regularly occurring peptide with the same precursor m/z as the
target, and is often called an isobaric peptide. Also, it can produce some of the same
fragments, or fragment m/zs, as the target, which means that some transitions are
shared among the target and interference peptides. It also means that as an
interference peptide passes through the QQQ, it produces a signal for any shared
transitions that are being monitored.
Interference can be remedied through careful transition selection, as exemplified by
selecting larger peptides, selecting larger fragments, selecting more fragments, and
using early MRM’s as feedback for designing later ones. Larger peptides, between ~10
to ~25 amino acids long, make better selections for a couple of reasons. First, these
peptides most often exist as +2 ions, and although they can form ions of +3 or higher,
few of them have to in order fit the QQQ’s mass range of 30 to 1500 Daltons. Second,
a large peptide can produce large fragments, and a large number of fragments. Large
fragments, such as b/y-6 to b/y-12 ions, have greater portions of their peptide’s
sequence, which gives the fragments a less replicable m/z and makes them more
characteristic of the target peptide. And with a larger number of fragments, comes a
lower chance that a significant number of them will be shared with any one isobaric
peptide.
All of the above translates into large peptides having more transitions that are more
unique and more likely to occur. Additionally, targeting numerous transitions for each
peptide in an MRM provides more evidence on which to determine authenticity. Finally,
the results of the MRM can be used to identify which transitions are shared, which are
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unique, and how the unique compare in signal strength. With this information, the
transition list can be purged of shared transitions followed by the weakest, until 3 to 6 of
the strongest and most confident transitions per peptide remain for further MRMs. This
dramatically improves confidence in peptide I.D. and subsequently protein I.D. It is with
this high level of confidence exhibited in proteomic MRM, that the QQQ deflates the
effects of low resolution.
As important as it is to have many peptides and transitions, there are limitations and
performance tradeoffs. One explicit limitation in the QQQ software’s operating
parameters is that the transition list is limited to 320 transitions and cannot have
duplicates. Notable performance tradeoffs exist between list size and duty cycle, as
well as scan time and sensitivity. Duty cycle is a transition’s scan time as a percentage
of the list’s scan time. Only one transition can be scanned at a time, and the entire list
must be scanned before starting again; so as the list increases, the scan time
increases, and transition duty cycle decreases. And although a transition can be
scanned in 1ms, it comes at the expense of lost sensitivity; conversely, in order to
increase sensitivity, scan time must increase as well. Thus, even if scans take only
tens of milliseconds, having a large list scanned with high sensitivity means those
milliseconds add up; meanwhile, the peptides continuously flow off the column, each for
a limited amount of time, and many for as little as 30 seconds. With a list of 320
transitions, each transition has a duty cycle 0.31% of the scan time, and at 20ms per
scan, each will be scanned once every 6.4s. If a peptide elutes for 30 seconds, a
transition will only be scanned 4 or 5 times, which means at best 5 data points will be
acquired to plot a transition’s entire profile. But a list of 75 transitions provides each
transition with a duty cycle of 1.3%, which translates to 20 data points. Therefore, it is
best to limit the number of peptides per protein, and transitions per peptide to the top 3
to 6 each. And when an experiment requires a large number of transitions, there will
need to be a compromise between the amount scanned in one run, and the quality of
each. The targeted MS/MS experiments in this study were run with a scan time of
20ms, with the offset voltage individually set for each transition as will be explained
below. The transition lists ranged in size from the mid 70’s to the 310’s depending on
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the nature of the MRM experiment.

2.8 Bioinformatics Methods for Data Analysis
Proteomic MRM design requires prior knowledge on proteins, peptides, and
transitions. Specifically, transition list selection requires data on which peptides are
unique to protein, and which precursor and fragment m/zs represent the most unique
transitions; this data must also provide the suitability of each peptide, precursor, and
fragment for MS/MS detection. As will be extensively discussed in chapter 4, this data
can be generated and evaluated through empirical measurements or theoretical
calculations. However, neither route is possible without precise sample information that
includes organism identity, protein sequence, protease identity, peptide length, peptide
sequence, number of missed peptide cleavages, fragmentation mechanism, and
fragment ion type. Reading, matching, calculating, and processing this information
would be impossible without a work belt full of purpose built software tools.
As mentioned above, this study presents two methods to gauge which peptides will
be best detected in MRM. The first will be called the empirical method, and employs
measurements attained with traditional global MS, such as those made on the LTQ.
The second method will be termed the ab initio method, and like its namesake, it relies
solely on theoretically calculated probabilities. An exhaustive comparison of these two
methods is offered in chapter 4, but what follows is a comprehensive list of the
programs and scripts used by each method, along with a brief description of their
functionality.
Empirically employed software extracts a variety of technical data on proteins and
peptides from MS1 and MS2 measurements, which are generated by global MS and
contained in a raw file. After an MS experiment, the raw file and a sample-specific
protein database, called a FASTA, are loaded into MyriMatch[22], which is also given
the protease I.D., fragmentation mechanism, and number of missed cleavages to allow.
MyriMatch then predicts peptides from the FASTA according to the given settings and
reads the raw file for matches. These matches are displayed in IDPicker[23] and
provide identities for proteins and their peptides, along with showing the associated
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peptide MS2 spectra. Having a list of each protein’s peptides, and knowing how they
fragment, is the first step in selecting peptides and transitions.
Picking the best fragments for each transition can be done straightforwardly by
looking at a peptide’s MS2 spectra. But selecting the best peptides to start with takes
further navigation, and offers several paths that focus on different qualifiers. Two paths
were followed in this study, one in chapter 3 and one in chapter 4, and each was laid
out with different software. The characterization study in chapter 3 required software
that assisted in defining discrete time bins. This same software was used to evaluate
each peptide’s abundance for their guided selection. Chapter 4 had no such time
constraint, which allowed the use of software that provided a more comprehensive
evaluation of peptide abundance.
The first path used an in-house script called gitR_MS that reads IDPicker results and
matches peptides to their MS1 scan number. Then, MASIC[24] reads the raw file
mentioned above to match MS1 scan numbers with their scan times and the ion current
for each m/z in a given MS1scan, and it calculates the total ion current (TIC) for that
scan. The peptides are matched to their MS1 scan times and ion currents to
simultaneously provide the time stamp and abundance. Here, peptide abundance is
defined by a peptide’s percent contribution to the TIC of the MS1 scan in which it was
found.
The second path is laid out by another in-house script named POSI, which uploads
the IDPicker files and the FASTA to match peptides to their multiple MS2 scan
intensities, a combination termed matched ion intensity (MII). The MIIs for each peptide
were summed and averaged across the number of MS2 scans for that peptide; peptide
abundance in this path is defined by the log of the product of a peptide’s summed MII
and averaged MII. This means that abundance here considers both the quantity and
quality of MS2 scans for a peptide.
The software employed by the ab initio method provides probabilities and scores to
assist in transition selection, and operates by internal calculations done on user
provided input, according to user defined parameters. Peptide selection was guided by
PeptideSieve[25], which uploads a FASTA and is given the protease I.D., peptide
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lengths to allow, number of missed cleavages to allow, and ionization method. It
generates a list of predicted peptide sequences, and assigns them detection
probabilities based on their amino acid composition and physiochemical properties.
After picking peptides, fragment selection begins with assistance from PepNovo[26].
PepNovo is given a list of peptide sequences and charge states, and instructed on what
fragmentation method, protease I.D., and post translational modifications (PTM) to
consider. It gives the top fragments for each peptide, the number of which is user
defined, and provides each fragment’s score based on length and amino acid
composition.
It’s important to note here, that the outputs from programs and scripts mentioned
above were loaded into excel for further extensive processing. Data processing tasks
performed in Microsoft Excel included, but were not limited to, searching, matching,
filtering, sorting, grouping, summing, averaging, ranking, highlighting, and graphing.
Although reams of informative input on MRM design came from several programs
and scripts, the actual MRM design and evaluation was performed solely with
Skyline[15]. Like some of the programs above, Skyline uses a FASTA and protease
I.D., and with these it generates a hierarchical transition list. The highest rank list is of
the proteins to be searched for and characterized, and each protein can be expanded to
display a list of its possible peptides. Each peptide can then be expanded to show its
possible precursor m/zs, and finally each precursor can be expanded into a list of its
possible fragment ions. This tiered approach can be seen in Figure 2.6. In Skyline, any
proteins, peptides, precursors, or fragments can be manually deleted from the list; doing
so, as guided by the scores and probabilities mentioned above, can provide a short list
of transitions with high probability and high duty cycle. Additionally, it can predict each
precursor’s optimum fragmentation energy and provide the corresponding offset
voltage. Once finished, Skyline can export a transition list file, which contains for each
transition: the precursor m/z to monitor in MS1, the offset voltage for optimum
fragmentation, and the fragment m/z to monitor MS2. Finally this file is uploaded to the
QQQ and guides it through an MRM experiment.
The use of Skyline does not end at exporting a transition list; when the MRM is
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Figure 2.6 Tiered display of proteins, peptides, precursors, and transitions as
seen in Skyline[15]
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done, the resulting raw file is uploaded into Skyline to evaluate the MRM design based
on each transition’s performance. Figure 2.7 demonstrates how the results are
presented in Skyline; it displays an overlay of the chromatograms of all transitions for
one peptide precursor at a time, and the intensities are shown relative to the highest
available for a given zoom. This overlay allows the user to quickly see which transitions
produced the highest peaks, which transitions have the least noise, and where on the
chromatogram transition peaks overlap. The latter is the most important in
authenticating that peaks originated from the desired peptide, and this will be discussed
further in chapter 3. Beyond displaying the chromatograms, Skyline also evaluates their
signals at a selected peak and offers individual ranks for each transition present in a
given selection, as shown on the left of Figure 2.7. Utilizing the chromatograms and
ranks, facilitates transition list improvement by showing which to keep and which to
discard or replace depending on the number.
Once the transition list is optimized, it can be used to run multiple technical
replicates of an MRM experiment, the results of which will again be loaded into Skyline.
The replicate chromatograms provide a ready visual for comparing retention times, peak
intensities, and peak area ratios. To facilitate this visual evaluation, Skyline can
produce bar charts and scatter plots of the transitions peak areas and retention times as
comparisons across peptides or across replicates. It can also provide numerical data
for exact comparisons of each peptide’s reproducibility by exporting a report on the
MRM results. Among a multitude of other metrics, a report can contain each transition’s
retention time and peak area, and each peptide’s retention time as a function of its best
transition, and peak area as a sum of its transitions. The report automatically displays
the data by replicate, but it can provide averages over all the replicates, along with
ranges, standard deviations, and coefficients of variability. By generating
chromatograms, charts, and reports, Skyline offers a comprehensive view of the results,
and provides a self-sufficient platform for evaluating MRM design.
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Figure 2.7 MRM results with transition ranks as displayed in Skyline[15]. Upper
left portion displays tiered approach, while different colored lines on the right
indicate separate transitions.
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2.9 Summary
This chapter laid out the experimental design of each project to provide a context for
the explanation of the materials and methods presented in this study. Within this
context was a description of the content of the 4-iso sample used for both projects,
offered as an argument of how this sample would challenge the scope, and characterize
the effects, of the complexity of a sample analyzed by MRM. The techniques used for
sample preparation and loading, as well as the LC method employed, were consistent
throughout each project; and as they lack offline fractionation or secondary
chromatography, they further emphasize the difficulty present in the analysis of this
sample. By explaining the operation of the spray source, it was shown how ionization
generates multiple peptide precursors. Operations of the both LTQ and QQQ were
covered and comparisons were made as to how each approaches tandem MS. These
comparisons showed how LTQ data functioned for both defining congestion and
empirically designing MRM, while the QQQ was the workhorse for all MRM experiments
and provided data characterizing and evaluating MRM performance. Finally, the
software was laid out to show how data was processed to provide definitive
measurements on MRM reproducibility in a complex sample.
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Chapter 3: Peptide Peaks Growing Up in a Tough Chromatographic
Neighborhood: Characterizing MRM Reproducibility and Robustness in Complex
Microbial Samples

3.1 Design of MRM Experiment
MRM is typically performed using one dimensional chromatography, which can be
problematic for very complex samples due to challenges from incomplete separations
and ion suppression leading to diminished reproducibility. The first project of this thesis
was tailored to evaluating such reproducibility under these conditions so that a
systematic method of selecting target peptides could be developed for MRM in complex
samples with 60 minute 1D-LC. This chapter chronicles the design and execution of
this project and begins with discussions on identifying congestion and abundance as
factors to be characterized for their influence on MRM quality, as well as the reason for
limiting the number of target peptides. Then, the mechanics of filtering the pool of
peptides down to the desired number will be detailed to explain how such filtering
defines areas of different chromatographic congestion. This will be followed by a
description on how three levels were established for peptide abundance, and how
peptides were selected to represent each level. Next, preliminary MRM will be
presented and justify the removal weak peptides from final MRM consideration. The
results of these MRMs will be the subject of the last sections of this chapter, which will
comment on the viability of MRM in complex samples, the influence of predicted factors,
and the identification of any unpredicted factors shown to have influence.
MS/MS analysis of peptides often employs complicated fractionation and secondary
separation techniques to minimize congestion in chromatographic flows to make low
abundance peptides more detectable. This is true even for simple samples such as
blood or urine. But with these simple samples, MRM is a regularly selected approach to
bypass additional separations as its targeted nature excels at ignoring congested areas
of the chromatogram to detect peptides of low abundance. Since complicated samples
present a substantial increase in congestion, and thus further bury low abundance
peptides, it was decided that these two factors, chromatographic congestion and
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peptide abundance warranted characterization during the evaluation of MRM
reproducibility in complex samples.
Only 12 to 36 peptides would be utilized for MRM evaluation, as this is a comparable
amount to what is targeted for MRM exploration of a metabolic process, and the
resultant MRM design would be tested on how reproducibly it measured this handful of
peptides from among more than 80,000 others in a 60 minute 1D-LC-MS/MS. These
targets would be selected from a pool of peptides identified by a series of global MS/MS
measurements. The peptides selected from this pool would have to possess the traits
necessary to characterize the effects of chromatographic congestion and peptide
abundance on MRM performance. The peptides would also undergo preliminary MRM
to determine which, if any, of their transitions were suitable for testing reproducibility.

3.2 Characterizing Viable Transitions from Selected Peptides
Four technical replicates, of a global measurement on the LTQ, yielded 3,827 nonredundant peptide identifications. To be considered candidates for the MRM evaluation,
identified peptides had to be reliably detected and time-specific. Table 3.1 contains a
partial list of these 3,827 peptides and their associated metrics. Five peptides on this
table, along with their scan times and replicate I.D. counts, are highlighted to exemplify
how a peptide was, or wasn’t, deemed reliable and specific.
Peptides were considered reliable if they appeared in all four replicates, as shown
on the right of Table 3.1 in green. This criterion is adjustable and could be relaxed to
provide more candidates if needed; for example, investigating a specific biological
process may require more options than what stricter criteria allow. However, selecting
peptides with lower reliability, such as those shown in yellow, risks diminishing MRM
reproducibility.
A peptide’s time-specificity was defined as the peptide having appeared in only one
5 min window per replicate, and the same five minute window across each replicate;
these five minute windows are referred to henceforth as bins. Examples of peptides
that were specific to one bin are shown on the left of Table 3.1 in yellow, while peptides
identified in more than one bin are in orange. It was considered essential that
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Table 3.1 Excerpt of peptide sequences with first and last scan times, and
replicate count. Qualities in green are favorable, qualities in yellow are
unfavorable. Peptides in blue qualify as candidates; peptides in red do not
qualify
Sequence
scan timeearliest (min) scan timelatest (min) Replicate Count
SKEHTTEHLR
0.00965
0.00965
1
SFSHQAGASSK
0.08764
0.08764
1
AQASTHGIGK
0.17481
4.74361
4
KQLDHGQK
0.42847
0.42847
1
TGRNPQTGK
0.51986
0.51986
1
TQDATHGNSLSHR
0.53575
3.65567
2
KLKDEAAK
0.7896
0.7896
1
APAAAAPAAK
1.4402
8.07177
4
SHALNATKR
1.46481
1.46481
1
VYVNKDDTTK
2.51166
6.18079
2
KVHPNDDVNK
1.55398
1.55398
1
MEQELHHR
1.71655
3.65567
2
APHVSEK
1.73009
1.73009
1
DAGGTAEAVR
6.52622
8.95852
4
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candidates be specific to a bin so that the chromatogram could be reliably divided into
segments of equal time but differing congestion.
Peptides such as those in blue were both reliable and specific, and were thus
candidates for MRM analysis. Peptides such as those in red lacked reliability, timespecificity, or both, and thus were not MRM candidates. 415 of the 3,827 identified
peptides were selected as candidates for MRM analysis.
The congestion of each bin was determined by how many of the 415 candidate
peptides were unique to it; Figure 3.1 and Figure 3.2 provide a visualization of how each
one differed in congestion. These figures show that the most congested bin is at 25 to
30 minutes, and that the majority of the peptides were identified between 10 and 45
minutes. This is because most peptides elute when the mobile phase is between 5%
and 40% ACN[27], and the gradient employed for this project increased from 5% to 60%
over 55 min. With chromatographic congestion adequately defined, its effect on MRM
quality would be characterized by examining how a peptide from one bin performed
relative to peptides from other bins. Performance would be measured in terms of a
peptide generating viable transitions that produced large sharp peaks with consistent
areas and retention times.
In order to evaluate how peptide abundance impacts MRM quality, different levels of
abundance were established, as displayed in Figure 3.1 and Figure 3.2, but it is
important to note that because abundances were often based on different MS1 scans,
comparing two ranks is not a comparison of absolute abundances, but of relative
abundances. That is to say, if one peptide were scanned among less abundant
peptides, while another was scanned among more abundant peptides, the former will
have a higher rank for its bin, even if the latter is more absolutely abundant.
Peptides with an average percentile rank of 75% to 100% were considered high
abundance level, peptides with 50% to 75% were medium level, and peptides with 25%
to 50% were low level; Figure 3.2 gives the abundance breakdown by bin. The effect of
peptide abundance on MRM quality would be characterized by comparing how high,
medium, and low abundance peptides performed relative to each other. Depending on
each bin’s availability, 3 peptides would be selected; the highest of the high abundant,
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Figure 3.1 Scatter-plot of peptide scan time versus abundance. Error bars are provided for abundance.
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the median of the medium abundant, and the lowest of the low abundant. The limited
availability of peptides from each abundance level within some bins led to a total of 31
selected peptides. Table 3.2 lists these 31 peptides, with their respective percentile
ranks, and grouped into their respective bins. It can be seen in the table that 4 bins did
not have all three possibilities. As there were only 13 of the 415 peptides with a rank
below 25%, and considering that these were only present in 3 of the 12 bins, it was
decided that none of them would be used to evaluate the effect of peptide abundance.

3.3 Evaluation of 31 Selected Peptides by MRM
The 31 representative peptides were subjected to preliminary MRM scans on the
QQQ to determine which, if any of their transitions were suitable for a reproducibility
study. Skyline software was used to predict the possible transitions for each of the 31
peptides, and to generate a target list for use in the preliminary MRM’s. Due to the
complexity in examining all possible transitions in a single MRM measurement, multiple
MRM’s were done to scan for the 720 possible transitions. The results were then
analyzed in Skyline to determine which transitions were suitable for MRM evaluation,
and which peptides had a sufficient number of transitions. Suitability was based on
consistency, signal strength, evidence of peak origin, and lack of ambiguity. Figure 3.3
shows 6 results of the preliminary MRM measurements. Each is a measurement of
transitions predicted for a target peptide, and illustrates how the best transitions were
selected for the final comprehensive MRM’s.
Transitions demonstrated consistency and signal strength through regular retention
times and a peak intensity of at least 104, with minimal noise. If a predicted transition
only produced random, low intensity peaks, then there would be too much difficulty in
distinguishing if the signal came from a fragmenting target peptide or just random noise.
Figure 3.3a and Figure 3.3b each show a spectra generated by the same three
transitions. The peaks displayed are of high intensity and regular occurrence, which
evidences fragmentation of the target peptide; hence these three transitions provide
useful information on their peptide. Figure 3.3c and Figure 3.3d also each show a
spectra generated by another same three transitions, but the peaks displayed are
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Table 3.2 The 31 selected peptides showing abundance and time bin. Shadowing
is to assist in time bin differentiation
Sequence
N/A
AQASTHGIGK
N/A
TPALAAK
NGGVAGNTTVNQK
LVEGSAQVK
TATEYGVVR
KVVVEYPK
VMQAQGSQLTNK
STC[57]TGVEMFRK
VDDGGTLDVR
LGSHNDMTFGEGTSSR
LGQMGELVR
TVSENEVPLYK
EFNVEANVGKPQVAYR
IEIPGC[57]SLC[57]MGNQAR
GPASVTNEQIEQVVR
FDGNAC[57]VLLNNNSEQPIGTR
LAATIAQLPDQIGAK
GIVDSNLGLSPATEGQVIR
VRELTVQATTGTNSESDLSSIQDEIK
VALYGIDYLMK
VIDLMC[57]PFAK
AVIFAGELLK
ANQVPQQVLSLLQG
VPDIGADEVEITEILVK
DIQLATPPQVGAPATEYAALAELK
VGAGPFPTELFDETGEFLC[57]K
GITLPETELR
N/A
ALLNSMVIGVTEGFTK
QSIAVSALSLANQSQQGVLQLLR
N/A
VLLPVPFALINDPFGK
LMEQITTSDELIDFLTLPGYR
N/A

Abundance
N/A
68.43%
N/A
93.56%
66.82%
35.23%
93.80%
65.19%
28.79%
78.87%
60.72%
25.20%
86.53%
62.27%
25.32%
91.99%
62.37%
28.36%
88.78%
61.73%
31.04%
92.50%
62.64%
37.94%
96.89%
61.45%
45.87%
76.35%
60.57%
N/A
84.54%
66.18%
N/A
88.72%
65.03%
N/A

Time Bin
0-5 min

5-10 min

10-15 min

15-20 min

20-25 min

25-30 min

30-35 min

35-40 min

40-45 min

45-50 min

50-55 min

55-60 min
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Figure 3.3 Excerpts from Preliminary MRM Results. Different line colors indicate
different transitions. a & b) Show two replicate measurements of the same
transitions for the peptide sequence AQASTHGIGK, which have high intensity
and minimal noise, and the insets show the transitions coincide, which makes
these ideal for final MRM. c & d) Show two replicates of the same transitions for
QSIAVSALSLANQSQQQGVLQLLR with low intensities and considerable noise,
making the unsuitable for final MRM. e) Shows that some transitions for
GITLPETELR also belong to an interference peptide of similar m/z, but there is
sufficient evidence to determine the leftmost peaks are from the target peptide,
while the others are from noise. f) Shows transitions for TPALAAK that also
belong to an interference peptide, but there is insufficient evidence to determine
target from noise.
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randomly occurring and low intensity. It is impossible to determine which, if any, of
these peaks are from the target peptide fragmentation, which makes these transitions
useless.
Suitable transitions also needed evidence that their peaks originated from the target
peptide, and not an interference peptide. This evidence of origination is provided by a
transition peak being part of a large set of coinciding transition peaks. Figure 3.3e
shows two sets of coinciding peaks. Both sets appeared because the transitions of
each are predicted for the target peptide. But only one set came from the target; the
other set comprises shared transitions and, came from an interference peptide. Since
Skyline predictions were tailored to target peptides, there should be more unique
transitions than shared, and so the target set should have more peaks. Thus, when
determining which peak set in Figure 3.3e originated from the target peptide, there is
more evidence for set on the left than the set on the right.
Finally, suitable transitions were required to be free of ambiguity, which was
demonstrated by generating only one coinciding set of high intensity peaks at a regular
retention time. Again, Figure 3.3a and Figure 3.3b show three predicted transitions,
whose high intensity peaks only coincide once, and so could only come from one
peptide, the target peptide. In Figure 3.3f there are three predicted transitions
producing high intensity peaks that coincide twice, and thus match to two different
peptides. The target peptide could be represented by either set, at least one set is from
an interference peptide, and it is possible that both sets are from interference peptides,
thus these transitions must be thrown out altogether.
Some transitions met many of the above criteria, produced strong spectra, and
appeared to be reliable candidates by initial inspections, but careful scrutiny yielded
subtle, yet fatal flaws. The insets in Figure 3.4a show two multi-transition sets, either of
which could be from the desired peptide or an interference peptide. The predicted
retention time favors the latter set, suggesting it is the desired peptide. However, Figure
3.4b shows only one transition set, yet the predicted retention time fails to match. This
set is reliably believed to be from the target peptide, which would indicate that these
complicated 1D-LC separations interfere with the reliability of current retention time
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Figure 3.4 Spectral anomalies resulting in MRM ambiguity. As before, different
colored lines indicate different transitions. a &b) Show inconsistency in
predicted retention time. a) Transitions for VALYGIDYLMK also match to
interference with equivalent evidence, but retention prediction favors the
rightmost peak. b) However, transitions for AQASTHGIGK only match the target
peptide while retention prediction fails to match. c & d) Show two replicates of
the same transitions for TPALAAK. These display further ambiguity as peptide
evidence and retention times switch between replicates.

40

predictions. Thus, the ambiguity in Figure 3.4a remains unresolved, and such peptides
must be discarded. Figures 3.4c and 3.4d show transition sets that are too close in
time, and even switch order. This makes it impossible to pick which transitions
represent the selected peptide, even if predicted times were reliable. Further
complication comes from the sets sharing at least four of their top transitions, thus
peptides like the one in Figures 3.4c and 3.4d must be discarded.
These target peptides could be salvaged as viable candidates with newer and more
discriminating methods for identifying the representative transitions. Calibrating the
predicted retention time calculator to better reflect unfractionated samples could help
the problem in Figure 3.4a, while peptides like the one in Figures 3.4c and 3.4d would
benefit from reliable transition score predictions that accurately show the rank of the
fragments for the target peptide.
Of the 31 selected peptides, 10 lacked suitable transitions and had to be discarded;
4 of these suffered from ambiguity created by interference peptides, and 6 produced
poor signal to noise ratios. Table 3.3 shows the ten discarded peptides and highlights a
few important observations. First, peptide abundance appears to have no effect in
determining which peptides are discarded. Also, chromatographic location shows no
apparent trend with a peptide having good transitions, but it does show a trend of early
eluting peptides suffering more from ambiguity, while later eluting peptides suffered
more from poor signal to noise.
The remaining 21 peptides were trimmed to 3 or 4 of their best transitions, and a list
was created to generate MRM results to evaluate reproducibility in a complex sample.
Figure 3.5 is an example of the MRM results analysis from Skyline. The best spectrum
(Figure 3.5a) came from a medium abundance peptide and show a peak with very high
intensity and no noise, but the worst spectrum (Figure 3.5b) is of greater interest
because it was obtained from a low abundance peptide and demonstrates how bad a
spectrum can look and still be useful. In spite of the contrast between Figures 3.5a and
3.5b, the latter’s set is still of sufficient intensity and the only one with coinciding peaks
(Figure 3.5b inset). This means that although Figure 3.5a is cleaner and 100 times
more intense than Figure 3.5b, both spectra yield valuable qualitative and quantitative
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Table 3.3 The 10 discarded peptides showing abundance, time bin, and reason for
discarding. Peptides in white were too ambiguous, while peptides in gray had too
much noise.
Sequence
TPALAAK
NGGVAGNTTVNQK
LGQMGELVR
VRELTVQATTGTNSESDLSSIQDEIK
VALYGIDYLMK
DIQLATPPQVGAPATEYAALAELK
ALLNSMVIGVTEGFTK
QSIAVSALSLANQSQQGVLQLLR
VLLPVPFALINDPFGK
LMEQITTSDELIDFLTLPGYR

Abundance
93.56%
66.82%
86.53%
31.04%
92.50%
45.87%
84.54%
66.18%
88.72%
65.03%

Time Bin
5-10 min
20-25 min
30-35 min
35-40 min
40-45 min
50-55 min
55-60 min

Reason
Ambiguous
Ambiguous
Ambiguous
Low Signal:Noise
Ambiguous
Low Signal:Noise
Low Signal:Noise
Low Signal:Noise
Low Signal:Noise
Low Signal:Noise
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Figure 3.5 Excerpts of final MRM results. As before different colored lines
indicate different transitions. a-c) Represent the strongest of the final MRM
spectra and show three replicates of the same transitions for TVSENEVPLYK
having high intensity, coinciding peaks, and consistent retention times. d-f)
Represent the weakest of the final MRM spectra and show three replicates of the
same transitions for VMQAQGSQLTNK, but insets show them as still having
adequate intensity, the only coinciding peaks in their respective spectra, and
consistent retention time.

43

information, and thus both are viable spectra. All 21 peptides produced viable spectra
with their selected transitions, regardless of their peptide abundance or
chromatographic congestion. This evidence supports conclusion that even in a
significantly complex sample, low abundance and high congestion do not prohibit
reliable MRM measurement in 60 minutes.
However, this conclusion and the results on which it is based, require that the
congestions and abundances, as established by global experiments, be similarly
maintained in targeted experiments. Although both global and targeted measurements
used the same LC flow rate, chromatographic issues could stem from the LTQ having
used a split-flow microflow pump while the QQQ employed a split-less nanoflow pump.
Similarly, the uniform use of quadrupoles and CID fragmentation could not ensure
abundance continuity since the LTQ and QQQ differ in mass analyzer configuration,
collision gas, and other intrinsic properties. Yet this inconsistency is less of a dilemma,
and more of a showcase for MRM software, as Skyline’s comprehensive data report
provides evidence for congestion and abundance being preserved across MS/MS
platforms.
A portion of data from Skyline’s report was used to generate Table 3.4, which
demonstrates the sustainment of congestion across MS platforms. This table shows
that although only 6 peptides eluted in their original bins, the order of elution was
maintained for 18 of the 21 peptides. It also shows that peptides originating from the
same bin remained close to or fewer than five minutes apart during MRM, with the
exception of only the last bin. Finally, this table displays that all retention time standard
deviations remained well below one minute across all three replicates.
As support for the preservation of peptide abundance, another selection of Skyline’s
report is employed by Table 3.5. Acknowledging that bin location was linked to both
determining abundance and selecting peptides by it, this table groups peptides
accordingly and then lists from lowest abundance to highest. In each bin, peptide order
by LTQ abundance is reflected in QQQ peak area, again with the exception of the last
bin. Table 3.5 also provides direct support for the above conclusion that MRM quality in
a complex sample is not measurably influenced by abundance or congestion.
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Table 3.4 The remaining 21 peptides comparing global MS/MS time to MRM time, and predicted order to detected
order. Blue values are more favorable, green values are favorable, yellow values are unfavorable
PeptideSequence
AQASTHGIGK
LVEGSAQVK
VMQAQGSQLTNK
KVVVEYPK
TATEYGVVR
VDDGGTLDVR
LGSHNDMTFGEGTSSR
STCTGVEMFRK
TVSENEVPLYK
EFNVEANVGKPQVAYR
GPASVTNEQIEQVVR
IEIPGCSLCMGNQAR
FDGNACVLLNNNSEQPIGTR
LAATIAQLPDQIGAK
GIVDSNLGLSPATEGQVIR
AVIFAGELLK
VIDLMCPFAK
ANQVPQQVLSLLQG
VPDIGADEVEITEILVK
GITLPETELR
VGAGPFPTELFDETGEFLCK

Global Bin
0-5
5-10
10-15

15-20
20-25
25-30
30-35
35-40
40-45
45-50

MRM Retention Time (min)
μ
σ
Range
15.24
0.20
N/A
8.42
0.23
N/A
3.99
0.55
5.05
0.69
1.8
5.81
0.51
6.79
0.31
7.97
0.23
1.4
8.19
0.26
15.06
0.23
5.5
20.53
0.51
23.07
0.47
28.79
0.61
6.4
29.49
0.64
32.22
0.65
3.4
35.63
0.61
39.27
0.48
4.1
43.37
0.66
52.56
0.60
2.0
54.52
0.34
26.54
0.54
29.4
55.92
0.15

Order
Pedicted
Detected
1st
9th
2nd
7th
3rd, 4th, 5th

1st, 2nd, 3rd

6th, 7th, 8th

4th, 5th, 6th

9th, 10th
11th, 12th, 13th
14th, 15th
16th, 17th

8th
10th
11th
13th, 14th
15th
16th
17th
18th

18th, 19th

19th, 20th

20th, 21st

12th
21st
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Table 3.5 The 21 remaining peptides showing factors of possible influence and
associated MRM performance. Blue values are more favorable, green values are
favorable, yellow values are neutrally acceptable, orange values are unfavorable,
red values are more unfavorable
PeptideSequence
AQASTHGIGK
LVEGSAQVK
VMQAQGSQLTNK
KVVVEYPK
TATEYGVVR
LGSHNDMTFGEGTSSR
VDDGGTLDVR
STCTGVEMFRK
EFNVEANVGKPQVAYR
TVSENEVPLYK
FDGNACVLLNNNSEQPIGTR
GPASVTNEQIEQVVR
IEIPGCSLCMGNQAR
GIVDSNLGLSPATEGQVIR
LAATIAQLPDQIGAK
AVIFAGELLK
VIDLMCPFAK
VPDIGADEVEITEILVK
ANQVPQQVLSLLQG
GITLPETELR
VGAGPFPTELFDETGEFLCK

Global
MRM Peak Area
Abundance Length
μ
Cv
68.43%
10 4.9E+06
0.07
35.23%
9 8.3E+05
0.73
28.79%
12 2.0E+05
0.73
10-15
65.19%
8 9.8E+05
0.09
93.80%
9 4.6E+06
0.87
25.20%
16 9.2E+05
0.60
15-20
60.72%
10 5.4E+06
0.27
78.87%
11 6.9E+06
0.43
25.32%
16 2.7E+06
0.55
20-25
62.27%
11 4.6E+07
0.26
28.36%
20 1.5E+06
0.22
25-30
62.37%
15 1.0E+07
0.34
91.99%
15 1.1E+07
0.17
61.73%
19 2.7E+06
0.02
30-35
88.78%
15 1.3E+07
0.07
37.94%
10 1.5E+06
0.33
35-40
62.64%
10 8.2E+06
0.19
61.45%
17 1.2E+06
0.24
40-45
96.89%
14 1.2E+07
0.16
60.57%
10 5.4E+06
0.29
45-50
76.35%
20 6.2E+05
0.10
Bin
0-5
5-10
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Comparing global abundances to MRM peak areas yields no clear trend, and the
tightest cluster of large peak areas is generated by the most congested part of the
chromatogram.
Aside from experimentally distancing complex sample MRM from the influence of the
predicted factors, this project revealed one influential factor that was not predicted
during its inception. Referring to Table 3.6 as an illustration, it was noticed that while
peptides of 10 amino acids or longer produced strong results with random exceptions,
peptides that were less than 10 amino acids consistently displayed less reproducibility if
any at all. Also referring back to Table 3.5, it would appear that lengths above 20 amino
acids are questionable targets. This information will prove to be relevant in chapter 4.

3.4 Summary
In this chapter a workflow was developed to select robust peptides for evaluating the
reproducibility of an MRM in a complex sample, containing more than 80,000 peptides,
with a 60 min 1D-LC-MS/MS. A discussion of MRM’s abeyance of peptide congestion
and abundance in small samples, as well as MRM’s typical target size, explained why
the workflow was also guided to pick approximately 2 dozen peptides for the evaluation
of each factor’s influence on MRM quality in a complex sample. Following this
discussion, the mechanics of the workflow were laid out to validate the characterization
of each factor’s influence. This discourse began by detailing how a pool of 3827
peptides was generated by global MS/MS, and then filtered down to 415 candidates in
order to define areas of differing chromatographic congestion and characterize
congestion effects on MRM reproducibility. The next section was dedicated to
explaining how the selection 31 peptides provided a range of abundances on which to
profile the influence of abundance on MRM quality. Preliminary MRMs of the 31
peptides were then presented and reviewed to demonstrate how the selected peptides
were themselves evaluated for suitability in testing both MRM quality and factor
influence; further explanation was offered as to why 10 peptides were rejected, leaving
21 for final MRM evaluations. After depicting the workflow, the final MRM results were
explored to reveal that all 21 peptides generated
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Table 3.6 MRM performances of peptides less than 10 amino acids long compared
to peptides 10 amino acids long. Blue values are more favorable, green values
are favorable, yellow values are neutrally acceptable, orange values are
unfavorable, red values are more unfavorable
Global
MRM Peak Area
PeptideSequence Bin
Abundance Length
μ
Cv
TPALAAK
5-10
93.56%
7 Discard
KVVVEYPK
10-15
65.19%
8 9.8E+05
0.09
LVEGSAQVK
5-10
35.23%
9 8.3E+05
0.73
TATEYGVVR
10-15
93.80%
9 4.6E+06
0.87
LGQMGELVR
20-25
86.53%
9 Discard
AQASTHGIGK
00-05
68.43%
10 4.9E+06
0.07
VDDGGTLDVR
15-20
60.72%
10 5.4E+06
0.27
AVIFAGELLK
35-40
37.94%
10 1.5E+06
0.33
VIDLMCPFAK
35-40
62.64%
10 8.2E+06
0.19
GITLPETELR
45-50
60.57%
10 5.4E+06
0.29
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reproducible spectra, which supported the verdict that MRM in a complex sample is
robust and minimally affected by congestion and abundance. Finally, excerpts from the
MRM data report were inspected to confirm the preservation of each factor, bolster the
final verdict, and also identify peptide length as unpredicted factor with a noticeable
influence on MRM quality.
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Chapter 4: Designing and Demonstrating Possible Experimental MRM-MS
Approaches for Characterizing Specific Metabolic Pathways of a Controlled
Bacterial Mixture

4.1 Experimental Design for MRM of a Metabolic Pathway
This chapter contains the second project of this thesis, which was developed to
profile a metabolic pathway in three organisms using MRM designed for complex
samples. It will begin with a quick discussion on the merits of selecting the TCA cycle
for this study, the origin for the comparison of the ab initio method to the empirical
method, and the application of conclusions from the previous chapter. Following this
discussion, will be descriptions on how MRM is employed to characterize a metabolic
pathway, precautions for designing such an MRM, and common criteria for both design
methods. Then, fundamental differences between the ab initio and empirical will be laid
out before beginning three comprehensive comparisons. The first will differentiate how
each method generates possibilities for building MRM transition lists, and it will contrast
the numbers generated by each. The second comparison will explain the uneven
protein selection as well as focus on how ab initio and empirical differed in ranking
precursors and fragments for peptide transition selection. The last comparison will
assess the MRM performance of each method, and provide a conclusion for the ability
of MRM to profile a pathway in a complex sample. This section will also include a
discussion of how the total numbers to tie back to availability, and how the results for
shared proteins point to improvements for the ab initio method.

4.2 Selection of a Biological Pathway
The TCA cycle was selected for this study based partially on its large number of
enzyme driven reactions and its universal availability, but it was chosen primarily for its
vital role in cell life. As seen in the lower part of Figure 4.1, it is a 10 to 12 step process,
and three organisms in the 4iso sample have well documented TCA cycles, E. coli, R.
pal, and I .hos; as N. equi relies on the TCA cycle of I. hos, it contains no cycle of its
own[16]. As for the criticality of this metabolic pathway to sustaining cellular life, the
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Figure 4.1 KEGG Cycle for TCA. The nine steps are highlighted to show the
enzyme commission numbers that were represented in all three organisms, and
to provide an understanding for the encompassing nature of the characterization
of this cycle[28]
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TCA cycle possesses a multifaceted role which is further increased by an ability to drive
its reactions in reverse order. The reverse TCA cycle is utilized by some bacteria, such
as I. hos, for carbon fixation and biosynthesis of amino acid precursors [16, 29], while
the forward process is central to the catabolism of carbohydrates, fats, and proteins for
all aerobic organisms. In the latter instance, the TCA cycle oxidizes the acetyl CoA
obtained from these biomolecules and generates adenosine triphosphate (ATP), which
is the primary form of intracellular chemical energy. For every 1 molecule of acetyl
CoA, TCA can generate 1 molecule of ATP directly and another 10 ATP molecules
indirectly through incident coenzymes [30]. This dexterous indispensability of the TCA
cycle will provide considerable gravity to demonstrating MRM profiling of a metabolic
pathway.
However, the conventionally employed empirical approach to MRM design proved
inadequate, as the preliminary data did not identify enough proteins to characterize the
cycle for I. hos. This represents a significant oversight in that I. hos provides an
uncommon profiling opportunity by possessing a uniquely augmentation to facilitate a
reversed TCA cycle [16]. The desire to characterize this rare pathway necessitated the
utilization of an ab initio method to guide the selection of proteins and peptides that
were missed by empirical means. Consequently, this project was enriched with the
secondary objective of comparing these two methods on availability and selection of
proteins and peptides, and on the performance of their respective MRMs. These two
design approaches also link the current project to the previous one by employing
conclusions from chapter 3; the ab initio method would avoid inclusion of peptides less
than 10 amino acids long, while the empirical method would use a redefined measure of
peptide abundance.
MRM characterizes a metabolic pathway by profiling the enzymatic proteins that
catalyze its major reactions; targeting a few unique proteins across the beginning,
middle, and end of a pathway can suffice for characterization. But as larger pathways
are considered, more proteins are needed; and naturally, studying more proteins for any
given pathway provides a more comprehensive understanding of that pathway as a
whole. Along with identifying these proteins by their peptides, MRM can profiles the
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proteins with the spectra generated by the peptide’s transitions. Under certain
circumstances, detecting one peptide precursor is sufficient for protein identity and
profiling, but identities and profiles are not independently reliable unless based on at
least two peptides with a combined three precursors. Thus an entire pathway should
not be characterized solely on proteins with single-peptide profiles, and even doing so
on dual-peptide profiles could be questionable. These profiles, and their underlying
identities, are more reliable when corroborated by an independent counterpart.
Designing an MRM to characterize a biological pathway involves careful evaluations
of proteins, peptides, and transitions in order to make good selections, but designing
that MRM to be done in 60 min, without fractionation, demands accurate knowledge on
the best selections at each level. It is important to remember that even the most
carefully selected peptides may evade detection, and some precursors may not be
generated in the ion source. Hence there is no certainty that a selected protein will be
identified, and proteins with just one peptide precursor are considered unreliable for
profiling. But each additional peptide renders its protein more reliable, and each reliable
protein provides more evidence for a metabolic pathway. So naturally, designing a
quality MRM for pathway characterization in a complex sample commands substantial
availabilities of proteins, peptides, and transitions.

4.3 Two Possible MRM Approaches
The ab initio and empirical methods shared three criteria for designing MRM. First,
TCA proteins were considered for profiling only if their enzyme commission number
(ECN) was represented in all the three organisms (highlighted in Figure 4.1) [16, 28].
This provided continuity on which to directly compare MRM performance in each
organism, and it naturally defined which proteins would be considered. One exception
was made for I. hos to include the four additional proteins that were critical to its
augmented cycle [16]. The final result included 7 ECNs in all three organisms, plus an
additional 4 for I. hos, for a total of 46 proteins among them. The second criterion was
the exclusion of peptides that contained missed cleavages, as this is an irregular
occurrence. Finally, the precursor ions for each peptide had to have m/zs less than
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1500 to stay within the QQQ’s mass range. The numbers available to each method, for
each organism, and at each level, are presented in Table 4.1; here gray numbers signify
a one to one relationship with the subordinate level. As stated before, MRM peptide
attrition rates rendered proteins with only one peptide as too unreliable for profiling.
And if a given TCA cycle had less than three reliable proteins with each representing a
different ECN, or if there were no independent proteins in the entire cycle, then an MRM
would not be designed for that cycle.
From this point on, fundamental differences between the ab initio approach and the
empirical approach would lay out separate paths for MRM design. The ab initio
approach is relatively new to MRM, and true to its namesake[31], it relies wholly upon
calculated models to score peptides, precursors, and fragments for transition selections.
This enables the ab initio method to consider all possibilities, but requires the
application of logical restrictions to prevent the unnecessary use of time and resource in
evaluating unlikely candidates. Also, as there are no preliminary MS/MS experiments,
this method carries an inherently higher degree of uncertainty. The empirical method is
the more traditional approach, and as stated before, takes guidance from preliminary
measurements. Although this provides proof that the target protein or peptide is
available, it is not a guarantee. Also, this method is limited to what was discovered in
the preliminary experiments, as any other options would lack the means to be scored.
The first comparison of MRM design by ab initio and empirical will focus on what
each method provided for selection, and will begin with empirical method as its selection
gave rise to this comparison study. The possibilities for empirical based MRM
comprised all proteins, peptides, precursors, and fragments that were identified in the
global MS/MS; this allowed any peptide length, and any precursor or fragment charge
state. The global data provided the empirical method with 7 E. coli proteins, and 5 R.
pal proteins, with all 12 proteins representing a different ECN. All proteins had at least
two precursors, and only one protein from each organism had only two precursors. As
for I. hos, the data provided only one protein that bore only two peptides, and regardless
of its lack of independence, this was clearly insufficient to support an empirical MRM of
I. hos, as was previously stated.
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Table 4.1 Number of available selections at each level. Gray numbers signify a
one to one relationship with the subordinate level.

e.coli
r.pal
Empirical
i.hos
Total
e.coli
r.pal
Ab Initio
i.hos
Total

Possible
Reaction Protein
Peptide Precursor
7
7
41
54
5
5
21
23
1
1
2
2
13
13
64
79
7
19
222
222
7
13
146
146
11
14
141
141
25
46
509
509
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The ab initio based MRM could consider any protein meeting the shared criteria, and
as this method was not limited to experimentally identified components, it could have
considered all possibilities of peptides, precursors, and fragments. However, this could
mean approximately 60 peptides for each of the 46 proteins; and each peptide would
average 6 precursors and 9 fragments, which translates into 378 transitions per peptide.
Aside from snowballing into an avalanche of options that would bury both Skyline and
its user in endless processing, most of these possibilities are not realistically feasible
under normal operating conditions; thus the majority of them were weeded out by
restricting the prediction parameters to only include the properties that were most
commonly observed. Specifically, peptide predictions were kept between 10 and 25
amino acids long, and transition predictions were limited to a +2 precursor charge with a
+1 fragment charge. Despite these restrictions, there were still two or more peptides
available to each of the 46 proteins, and any given TCA cycle could be characterized
solely by proteins that had 9 or more peptides available. This meant that every protein
was available its cycle, and each cycle had the potential for all of its proteins to be
independently profiled. Comparing the total numbers in Table 4.1 clearly demonstrates
that the ab initio method has more options at each level.
Table 4.2 displays direct comparisons of the availabilities for each method across
the shared organisms; but more importantly, it provides an understanding of the amount
that ab initio missed at the peptide and precursor level on account of its restrictions.
Comparing the shared numbers to the empirical numbers shows that ab initio
predictions failed to include a total of 7 peptides and 28 precursors that were found in
the global data. The lost peptides were filtered out by their lengths, which consequently
filtered out the 10 precursors found among them. However, 7 of those 10 would have
been eventually filtered out by their charge; such was the root of ab initio exclusion for
the remaining 18 precursors, as these belonged to shared peptides. Notably, 6 of these
18 were the only precursors to be empirically available to their respective peptides; this
explains why the number of shared peptides is 6 more than the number of shared
precursors. The importance of identifying the number and cause of these ab initio
exclusions will be covered in the following discussions of which peptide precursors were
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Table 4.2 Direct comparison by shared organism of number of available
selections at each level. Gray highlight emphasizes discrepancy between
number of shared peptides and number of shared precursors.

Possible
Reaction Protein
Peptide Precursor
Ab Initio
7
19
222
222
e.coli Empirical
7
7
41
54
7
7
35
29
Shared
Ab Initio
7
13
146
146
r.pal Empirical
5
5
21
23
5
5
20
20
Shared
Ab Initio
14
32
368
368
Both Empirical
12
12
62
77
12
12
55
49
Shared
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selected and detected.

4.4 The MRM Selection Process
With the possibilities defined, the scoring and selection process could begin. This
brings the second comparison of ab initio to empirical, which focuses on how each one
scored and selected peptide transitions at both the precursor and fragment levels; but
there is no comparison of protein level selections for three reasons. First, both methods
scored proteins with the average score of their top three precursors; ergo a comparison
of protein selections is merely a comparison of the underlying precursor selections.
Next, the empirical method provided no alternative proteins for any given ECN; thus a
protein level comparison would be made not between different methods of selection, but
between ab initio selection and empirical availability. Finally, the general lack of
proteins by empirical method was what led to the inclusion of the ab initio method, and
as the latter provided the only means for complete characterization in all three
organisms, it was decided to guide protein selections strictly primarily by their merits for
characterizing the ab initio method.
The protein selection numbers are summarized in Table 4.3 and show that ab initio,
selected 25 proteins; 15 were by default as no alternatives were available, and 10 were
by top score among alternatives. To test the effect of selecting a non-default ab initio
protein with an inferior probability average, the highest averaging protein was passed
for the next highest alternative in its ECN; this was E. coli’s p0115[28], and was
substituted with p0744. Despite having the inferior average in its own ECN, p0744 had
a higher average than 19 of the 24 proteins from the other ECNs. Checking for which
proteins were shared revealed that all 5 R. pal in empirical had been selected by ab
initio, and could therefore be used for comparison; this was a hardly coincidence
though, as four of these proteins were defaults. Ab initio also selected 5 of the 7 E. coli
proteins in empirical, with three by default and two by score. As for empirical’s two E.
coli proteins that were not selected, one was the above mentioned p0115. The other
protein was p0703, which was ranked by ab initio as second to p4043 for their ECN.
The impact of which proteins were selected and which were skipped will be addressed
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Table 4.3 Number selected at each level

e.coli
Empirical r.pal
Total
e.coli
r.pal
Ab Initio
i.hos
Total

Selected
Protein
Precursor Fragment
5
14
56
5
13
52
10
27
108
7
21
84
7
21
84
11
32
128
25
74
296

59

in the discussions on what was detected.
It could be argued that it would have been better to use p0703 to test inferiority in ab
initio ranks, which would allow p0115 to be selected, and thus all 7 empirical E. coli
proteins would be used. However, selecting these peptides presents two drawbacks.
First, the presence of p0115 is already known and so its profile would only characterize
selections of peptides and transitions; this in turn would mask the impact of ab initio
scores on protein selections. Second, using all 7 E. coli proteins for the comparison
would further disrupt empirical continuity between E. coli and R. pal.
With the proteins chosen, the selection process then moved to peptide and transition
levels, but since ab initio and empirical shared more peptides than precursors,
comparisons are better explained by currently referring to these levels as precursor and
fragment selections. Precursor selection required two to three precursors, representing
at least two different peptides in empirical’s case, based on availability and score. This
selection size maintained protein reliability and independence while minimizing MRM
duty cycle and the precursor selection numbers are given in Table 4.3. The empirical
method scored each precursor by its MII and had multiple precursors available to many
of its peptides, but it only selected the +2 precursor for all but one of its peptides; for this
peptide it selected the +2 and +3 precursors. For two of its proteins, empirical could
only select two precursors, and it selected none of the 10 precursors that were excluded
by ab initio restrictions; rendering these exclusions inconsequential. As for Ab initio
selection, a precursor’s calculated probability was used for its score, and only one
precursor was available per peptide, but ab initio selected three precursors for every
protein to have the maximum number of precursors for each organism. It should be
noted that a secondary check of peptide suitability, following this project’s data analysis,
resulted in the ex post facto removal of one I. hos precursor from the ab initio selection,
and one R. pal precursor from the empirical selection. These omissions are reflected in
all tables, but affected neither ab initio evaluation nor method comparison.
The final step in the selection process was selecting the top four fragments for each
precursor, where only fragments with m/zs less than 1500 were considered, and the
selection size was again chosen to maintain confidence in precursor identity while
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minimizing MRM duty cycle. Empirical selection was guided by a visual inspection of
each precursor’s fragment spectra, and the four fragments with most intense peaks
were selected. Naturally, the ab initio method offered no such spectra, but rather it
guided fragment selection with calculated scores similar to those it used for peptide
selection. Again, the total selection numbers are given in Table 4.3, and they show that
each method selected the maximum number of fragments for their precursors.
Table 4.4 focuses on shared E. coli and R. pal proteins to offer a direct comparison
of the ab initio method to the empirical. Although both methods effectively filled the
ranks, the ratios in this table make it is easier to see that each did so with mostly distinct
selections. The widest gaps exist at the fragment level, yet stem from differences in
precursor selections, more than fragment selections. Table 4.5 better illustrates this
point by drawing from both methods only the precursor numbers from shared proteins,
and only the fragment numbers from shared precursors. Looking at both organisms
together, a total 48 precursors were selected from the 10 shared proteins, but only 9
precursors were shared among both methods, and they came from only 6 proteins. As
a comparison, a total of 46 fragments were selected from those 9 precursors, and 26 of
those were shared and came from all 9 precursors. Hence, fragment selection was
more similar between the two methods than precursor selection.

4.5 Experimental Evaluation of the Two MRM Approaches
After the selections were made and the transition lists built, the MRM’s designed by
the ab initio and empirical methods were executed on the QQQ. The results were
analyzed with Skyline, where any transitions with weak or irregular signals were
discarded, and any precursor of less than three viable transitions was also discarded.
But as mentioned before, single precursor detections were sufficient for identification
and profiling, provided that an independent protein was present in the same methodorganism scenario. Table 4.6 lists the targeted proteins by their ECNs and its numbers
affirm the successful MRM profiling of the TCA cycle in a complex sample with all five
scenarios providing no less than 4 profiled proteins, and at least one of which was
independent. As neither method consistently produced better MRM peak intensities,
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Table 4.4 Direct comparison by shared protein of number selected at each level,
also showing number shared for each organism over total for each organism

Selected
Protein
Precursor Fragment
Ab Initio
5
15
60
e.coli Empirical
5
14
56
Sha/Tot
5/5
4/25
10/106
Ab Initio
5
15
60
r.pal Empirical
5
13
52
Sha/Tot
5/5
5/23
16/96
Ab Initio
10
30
120
Both Empirical
10
27
108
Sha/Tot
10/10
9/48
26/202

Table 4.5 Number of shared precursors per protein, and number of shared
fragments per precursor by organism

Unit: Precursor Fragment
Base: Protein
Precursor
Shared Bases
5
4
Bases with Shared Units
3
4
e.coli
Units from Shared Bases
25
22
Shared Units
4
10
Shared Bases
5
5
Bases with Shared Units
3
5
r.pal
Units from Shared Bases
23
24
Shared Units
5
16
Shared Bases
10
9
Bases with Shared Units
6
9
Both
Units from Shared Bases
48
46
Shared Units
9
26
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Table 4.6 Targeted proteins as identified by their ECNs and showing number of
precursors detected per protein by organism and method. N/A is no protein
available for that ECN; N/E is ab initio selected protein not available to empirical.
Blue highlighting shows ab initio exclusive protein profiles.

Enzyme
e.coli
r.pal
i.hos
Commision Ab initio Empirical Ab initio Empirical Ab initio
2.3.3.1
1
3
3
3
4.2.1.3
0
N/E
1
2
1.1.1.42
3
2
1
2
6.2.1.5
3
3
2
2
1.3.99.1
1
N/E
1
N/A
4.2.1.2
2
0
1
N/A
1.1.1.37
2
2
2
3
1.2.1.11
6.2.1
reactions unique to i.hos
4.2.1.120
4.2.1.55

Em
2
N/A
1
1 N/E
2
3
0
3
N/A
2
1
2
2
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the final comparison of the ab initio and empirical was left to the numbers of detected
proteins, precursors, and fragments as shown in Tables 4.6 and 4.7. The general
impression from both tables is that ab initio and empirical performances were
comparable, with both methods missing one protein each in E. coli, profiling all of their
target R. pal proteins, and detecting similar numbers of peptides in each organism.
However, there are some obvious differences and some subtle differences, which
together point to important conclusions, all of which are discussed below.
The numbers in Table 4.7 reveal that ab initio generated 14 more protein profiles
than empirical, and more than 71% of the total protein profiles. The highlighting in
Table 4.6 shows that these additional profiles arose from 10 I. hos proteins, 2 R. pal
proteins, and 1 E. coli protein that were not discovered by empirical’s global MS/MS.
The remaining additional profile arose from ab initio selecting two of its exclusive
peptides to detect a protein that empirical selections missed. These detection statistics
point back to the beginning of this project and affirm that ab initio is stronger than
empirical in regards to availability of proteins and peptides. The advantage of this
strength is exemplified by ab initio’s exclusive profiling of the I. hos reverse TCA cycle,
and is further bolstered by full inclusion of the critical augmentation to this cycle as
highlighted in Figure 4.2.
Connecting to another earlier discussion, the E. coli protein that was missed by ab
initio was p0744, which was selected over p0115 to the test a second rank selection.
This loss was despite p0744 having a higher average than many of the first ranked
proteins, and it is made even more unique by being the only non-default protein to be
missed by either method. Although it does not conclusively measure the effect of ab
initio score order on MRM selection, this loss does invite further investigation on the
topic.
Another interesting aspect about p0744 is that it was one of only two proteins that
were not available to empirical while representing ECNs that were; the other was
p0703, which was ranked first place by ab initio and detected by MRM. This means
p0744 was the only targeted protein that was deemed inferior by both methods, and it
was the only portion of the E. coli TCA cycle to be missed by both methods. The latter
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Table 4.7 Number of detected at each level

e.coli
Empirical r.pal
Total
e.coli
r.pal
Ab Initio
i.hos
Total

Detected
Protein
Precursor Fragment
4
10
35
5
12
44
9
22
79
6
12
45
7
11
38
10
19
76
23
42
159
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Figure 4.2 Excerpt from the updated reconstruction of I. hos metabolism showing
the augmented reverse TCA cycle for carbon fixation [16]. The numbers that are
highlighted and underlined in black identify the I. hos proteins for the standard
TCA cycle that were successfully profiled. The numbers with blue emphasis
identify the successfully profiled proteins of the I. hos exclusive augmentation,
and they demonstrate the full inclusion of this critical addition by MRM pathway
profiling.
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statement points to the proteins of both organisms being well profiled across ab initio
and empirical MRMs together, and is demonstrated in Table 4.8 by comparing the
numbers of either method to the combined numbers. It may seem like an obvious
outcome that the methods would perform better together than separately, but what is
less pronounced is that a similar performance could be achieved by just one method,
the ab initio method.
Considering each method’s numbers for only the shared ECNs, as seen in Table
4.9, empirical has virtually exhausted its protein options, and is much closer to its limit of
possible precursors than ab initio, hence there is little room for improvement for the
former. Conversely, Table 4.9 demonstrates a wealth of options available to ab initio,
and aids in method improvement by eliminating protein selection from consideration.
Recalling from Table 4.5, the methods differ less in fragment selection, which focuses
improvement measures on increasing peptide precursor selection. Looking at the
detected precursor numbers from Table 4.9 reveals that 13 detected precursors were
selected by the empirical method. One of these was the aforementioned +3 selection,
which was excluded from ab initio availability. But as was also mentioned, each
remaining precursor was +2 and came from a separate peptide, none of which were
excluded by ab initio. Thus the 12 peptides that were selected only by empirical were
still available to ab initio selection, 5 for E. coli and 7 for R. pal. However, increasing the
ab initio selection number by just one peptide can bring a significant increase to
transition list size, as this addition is multiplied across 7 proteins for each organism and
further multiplied by 4 transitions for each peptide. Thus a compromise must be met
between decreasing duty cycle and improving ab initio MRM quality. Table 4.10
displays the balance between assimilating empirical selections and overloading
transition list. From this table, it can be determined that selecting the top 5 or top 6
peptides for ab initio would result in an appreciable increase of MRM quality, without
sacrificing significant duty cycle. Thus the ab initio method can single-handedly provide
a more complete TCA profile.
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Table 4.8 Direct comparison by shared protein of number detected at each level
Detected
Protein
Precursor Fragment
Ab Initio
5
11
42
e.coli Empirical
4
10
35
Combined
5
17
67
Ab Initio
5
9
30
r.pal Empirical
5
12
44
Combined
5
16
59
Ab Initio
10
20
72
Both Empirical
9
22
79
Combined
10
33
126
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Table 4.9 Direct comparison by shared ECNs of numbers available, selected, and detected at each level
Protein
Pecursor
Fragment
Possible Selected Detected Possible Selected Detected Selected Detected
Ab Initio
19
5
5
222
15
11
60
42
e.coli Empirical
7
5
4
54
14
10
56
35
Shared
7
5
4
29
4
4
10
10
Ab Initio
6
5
5
84
15
9
84
30
r.pal Empirical
5
5
5
23
13
12
52
44
Shared
5
5
5
20
5
5
16
15
Ab Initio
25
10
10
306
30
20
120
72
Both Empirical
12
10
9
77
27
22
108
79
Shared
12
10
9
49
9
9
26
25
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Table 4.10 Comparison of top n selections showing the number of empirical
selections assimilated, number of total peptides, and number of total transitions.
Dark blue values are most desirable, light blue values are more desirable, purple
values are desirable, light red values are less desirable, and dark red values are
least desirable.

Pick

Peptides
Transitions
Emprical Total
top 3
0
21
84
top 4
0
28
112
top 5
2
35
140
e.coli
top 6
2
42
168
top 9
3
63
252
top 12
5
77
308
top 3
top 4
top 5
r.pal
top 6
top 9
top 12

0
1
3
5
6
7

21
28
35
42
63
83

84
112
140
168
252
332
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4.6 Summary
The chapter presented the project of applying MRMs designed for complex samples to
profile the proteins of TCA cycles for E. coli, R. pal, and I. hos. As global MS/MS
provided insufficient empirical data to design MRMs for all three organisms, this project
introduces an ab initio approach to MRM design, which presented the opportunity to
compare two competing methods. This project also took heed of the previous chapter’s
conclusion on peptide length by applying it to the ab initio method for designing MRM,
as well as applying the conclusion on peptide abundance by changing its definition for
the empirical method in this chapter. An explanation of how MRM profiles a metabolic
pathway provided context for the common precautions and criteria observed by both ab
initio and empirical, then a fundamental contrast set the stage for their three
comprehensive comparisons. The two methods were first evaluated on what each
provided in terms of proteins, peptides, and precursors. As the empirical method’s
deficiency was the origin for this comparison study, it is no surprise that ab initio had the
clear advantage in numbers possible at each level; ab initio was also shown to provide
both a better opportunity for profiling R. pal’s cycle and the only opportunity for I. hos.
The methods were then assessed for diversity in selections of precursors and
fragments, and it was demonstrated that they differed more in their ranking of
precursors than that of fragments. The final comparison was based on the detection
results of each methods design, which revealed that MRM profiling of metabolic
pathways in a complex sample is achievable, and the methods are essentially even in
selecting viable peptides and transitions for shared proteins. But, ab initio’s strength in
availability was proven to be of vital importance as it enabled this method to solely
profile the TCA cycle of I. hos, and to assimilate some precursor selections that were
originally unique to empirical, thereby granting ab initio the ability to increase its MRM
performance.
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Chapter 5: Discussion
The objective of this thesis was to expand the scope of the MRM approach in
proteomics to include the reproducible analysis of complex samples without the
assistance of extensive sample preparation. This goal was achieved by executing two
projects which dually demonstrated an increased understanding of MRM capability, and
provided depth for this understanding through the success of secondary objectives.
The first project affirmed MRM reproducibility in a complex sample through the
demonstration of robust peptide measurements, as evidenced by characterization of the
influence of predicted and unpredicted factors on MRM quality. The second project
illustrated the significance of complex sample MRM design by successfully profiling the
same metabolic pathway in three microbes from the same complicated sample. This
project further displayed the value of MRMs in a complicated mixture through a
comparison of two evenly matched approaches for MRM design.
By meeting the objectives of both projects, the work presented in this thesis
successfully challenged conventional perceptions of MRM limitations. Compared to the
traditional MRM samples of blood, plasma, or urine, the 4iso sample presented a vast
labyrinth with the complete proteomes of E. coli, R. pal, I. hos, and N. equi. Next, the
TCA cycle was an ideal pathway choice because of its large number of enzymatic
reactions and its presence in three of the organisms, but mostly because of its vital role
in cell life. Finally, the conventional complex sample strategies of fractionation, 2D-LC,
and 24 hour run-times were eliminated by the employment of 60 minute 1D-LC-MS/MS.
In the first thesis project (chapter 3), the generation of reproducible spectra for
selected peptides from the 4iso sample validated both the MRM of complex samples,
and the workflow developed to design and evaluate those MRMs. From global MS/MS
results for a pool of over three thousand peptides, this workflow sufficiently defined
regions of differing chromatographic congestion by identifying at least four hundred
candidates that were consistently detected, and could be grouped into 5 minute bins.
This workflow also provided an appropriate range in peptide abundance by defining
three levels therein and identifying one peptide from each level for each bin. The
explanation for removing weak peptides also provided characterization of peptide length
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as an unpredicted third influential factor, while congestion and abundance were well
characterized on the results of the 3 replicate MRMs of the remaining peptides. These
characterizations defend the conclusions that congestion and abundance have little if
any influence on MRM quality in a complex sample, while peptide length is a more likely
source of loss.
The second related thesis project (chapter 4) built on the conclusions from the
chapter 3 work to accomplish the goal of MRM characterization for the TCA cycles in a
complex sample, while also providing a venue for the comparison of the ab initio and
empirical methods for MRM design. Assessing each method on their availability
numbers proved ab initio’s advantage in making more proteins accessible for attempted
profiling, while examining diversity in selection revealed that the methods differed most
in how each scored precursors. Although the detection numbers revealed that ab initio
and empirical were relatively equal in performance on shared proteins, they also clearly
demonstrated that ab initio’s strength in availability provided more total profiles and
greater opportunity for improvement.
Through the demonstration of both MRMs capabilities in complex samples, and ab
initio’s comparable performance in MRM design, this thesis has authenticated a method
for metabolic profiling that requires minimal sample preparation and preliminary
measurements. The reduced cost in time and money by applying such a method
carries the potential to greatly increase the wide-spread application of proteomic
research, as well as the number of complete profiles generated in one study. The
predictive software and bioinformatics programs used in this study are freely available,
and the QQQ platform on which the MRMs were performed is among the most
attainable instruments. Even if a researcher cannot afford such an instrument and must
borrow time on one from another lab, the minimal sample preparation means that most
of the design can be carried out in an office, allowing for a more efficient use of
instrument time. Utilizing ab initio MRM design to profile metabolic pathways in
complex samples allows researchers greater accessibility for contributing to the evergrowing proteomics field and its parent field of systems biology.
Many improvements to method design, separation, and instrumentation are on the
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horizon, as suggested by this and related studies. For example, further research into
the effect of peptide length on MRM quality could produce filters that reduce the
availability of less meaningful peptides. Also, as explicitly noted, selecting the top 5 or
top 6 rated precursors provides a confident expectation of improving MRM quality.
Improvements to 1D-LC could further reduce sample complication, or alternately allow
even more complex samples to be attempted. Specifically, improvements to retention
time prediction software could recover some the peptides lost to ambiguity, by providing
more a confident chromatographic identity. As for instrumentation, the aforementioned
Q-Exactive is becoming increasingly popular in proteomic MRM, and represents a
substantial leap forward in acquiring MRM data at superior mass resolution and
accuracies, thereby reducing ambiguity and interference overlaps. Performing
improved ab initio based MRMs of complex samples on such an instrument while
utilizing the latest updates to 1D-LC will provide the ultra-fast and highly accurate
metabolic pathway profiles necessary to feed the rapidly increasing demand for
comprehensive protein level views of cellular genetic expression.
In total, the MRM-MS approach has seen remarkable advancements and
implementation in recent proteome research applications. While the MRM-MS method
has been widely used in other scientific arenas, the application to systems biology is a
recent venue. The work demonstrated in this thesis assists in defining the experimental
landscape for this methodology by systematically examining how to best define and
optimize approaches for high-throughput measurements of moderately complex
microbial systems.
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